ARTICLE | Clinical News
Stelara ustekinumab regulatory update
December 10, 2012 8:00 AM UTC
Johnson & Johnson submitted an sBLA to FDA and a Type II variation to EMA to expand the label of Stelara ustekinumab to include treatment of active psoriatic arthritis in adults. Stelara is approved i...